Skip to main content
SpringerLink
Log in

Primary Prevention of Genetic Disorders and Place of Preimplantation Genetic Diagnosis

  • Chapter
Practical Preimplantation Genetic Diagnosis

  • 784 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stoll C, Alembik Y, Dott B, Roth MP. Impact of prenatal diagnosis on livebirth prevalence of children with congenital anomalies. Annales de Genetique 2002;45:115–121.

    PubMed  Google Scholar 

  2. EUROCAT Report No. 8. Surveillance of congenital anomalies in Europe 1980–1999. Edited by EUROCAT WorkingGroup. EUROCAT Central Registry, Room 1F08, University of Ulster Nowtownabbey, County Antrim, Northern Ireland BT37 0QB. Email eurocat@ulster.ac.uk.

    Google Scholar 

  3. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991;338:131–137.

    Google Scholar 

  4. Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects 1983–1991. MMWR 1991;40:513–516.

    Google Scholar 

  5. Czeizel AE, Dudás I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832–1835.

    Article  PubMed  CAS  Google Scholar 

  6. US Department of Health and Human Services, Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996;61:8781–8807.

    Google Scholar 

  7. Czeizel AE. Primary prevention of neural-tube defects and some other major congenital abnormalities. Pediatr Drugs 2000;2:437–449.

    CAS  Google Scholar 

  8. Wald NJ, Noble J. Primary prevention of neural tube defects. In: Rodeck CH, Whittle MJ (eds.). Fetal Medicine: Basic Science and Clinical Practice. Churchill Livingstone, London, 1999, pp. 283–290.

    Google Scholar 

  9. Berry CJ, Li Z, Erickson JD. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999;341:1485–1490.

    Article  PubMed  CAS  Google Scholar 

  10. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991–1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999;131:331–339.

    PubMed  CAS  Google Scholar 

  11. Ruddell LJ, Chisholm A, Williams S, Mann JI. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr 2000;71:1448–1454.

    Google Scholar 

  12. Olney RS, Mulinare J. Trends in neural tube defect prevalence, folic acid fortification, and vitamin supplement use. Semin Perinatol 2002;26:277–285.

    PubMed  Google Scholar 

  13. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. Br Med J 2002; 325:1202.

    Google Scholar 

  14. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001;345:1593–1600.

    Article  PubMed  CAS  Google Scholar 

  15. La Vecchia C, Negri E, Pelucchi C, Franceschi S. Dietary folate and colorectal cancer. Int J Cancer 2002;102:545–547.

    PubMed  Google Scholar 

  16. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002;33:2351–2356.

    Article  PubMed  CAS  Google Scholar 

  17. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C→T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA 2002;288:2023–2031.

    Article  PubMed  CAS  Google Scholar 

  18. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, Weir DG, Scott JM, Whitehead AS. The “thermolabile” variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64:1045–1055.

    Article  PubMed  CAS  Google Scholar 

  19. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O’Leary VB, Parle-McDermott A, Scott JM, Swanson DA. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet 2002;71:1207–1215.

    Article  PubMed  CAS  Google Scholar 

  20. Moat SJ, Ashfield-Watt PA, Powers HJ, Newcombe RG, McDowell IF. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem 2003;49:295–302.

    PubMed  CAS  Google Scholar 

  21. Wald NJ. Folic acid and neural tube defects. In: Walter P, Hornig D, Moser U (eds.). Functions of vitamins beyond recommended dietary allowances. Bibl Nutr Diet Karger, Basel, 2001, No.55, pp. 22–33.

    Google Scholar 

  22. Department of Health. Report on Health and Social Subjects. 50. Folic Acid and the Prevention of Disease: Report of Committee on Medical Aspects of Food and Nutrition Policy. The Stationery Office, London, 2000.

    Google Scholar 

  23. Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Folate intake and the risk of neural tube defects: An estimation of dose-response. Epidemiology 2003;14: 200–205.

    Article  PubMed  Google Scholar 

  24. Raats M, Thorpe L, Hurren C, Elliott K. Changing preconceptions: The HEA folic acid campaign 1995–98. Health Education Authority 2, London, 1998.

    Google Scholar 

  25. Report of WHO/EURO Meeting on Development of EURO Strategy on Congenital Disorders. Minsk, November 29-30, 2001. Unpublished WHO/EURO Document (#51203630). WHO, Copenhagen, Denmark.

    Google Scholar 

  26. Report of the WHO/EURO Meeting on the Regional Policy for Prevention of Congenital Disorders. Folic acid: From research to public health practice. Rome, November 11–12, 2002. Instituto Superiore di Sanita, Rome, Italy.

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag London Limited

About this chapter

Cite this chapter

(2005). Primary Prevention of Genetic Disorders and Place of Preimplantation Genetic Diagnosis. In: Practical Preimplantation Genetic Diagnosis. Springer, London. https://doi.org/10.1007/1-84628-139-3_1

Download citation

  • DOI: https://doi.org/10.1007/1-84628-139-3_1

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-920-3

  • Online ISBN: 978-1-84628-139-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation